Jun 08, 2022 / 01:00PM GMT
Jing Deng - Jefferies LLC - Senior Research Associate, Biotechnology
Hello, everyone. I'm Jing Deng, and then, I'm the Senior Associate in Biotech of Maury Raycroft's team, and then -- at Jefferies. I'm so happy to introduce our guest today, David Cory, President and CEO at Eiger BioPharmaceuticals. And then, this is a presentation format, so let's welcome David. And then, we're excited to hear what you are going to share with us.
David Cory - Eiger BioPharmaceuticals, Inc. - President, CEO, & Director
Thank you very much, Jing.
Jing Deng - Jefferies LLC - Senior Research Associate, Biotechnology
Maybe after this, we can have a Q&A session.
David Cory - Eiger BioPharmaceuticals, Inc. - President, CEO, & Director
Sounds fine. Sounds fine, thank you very much, Jing. And good morning, everyone. My name is David Cory, and I'm the President and CEO of Eiger. Thanks to the Jefferies team for allowing us to participate at the conference today. As many of you may know,
Eiger BioPharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot